BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

F2G Ltd 

The Manchester Incubator Building
Grafton Street
Manchester    M139XX  United Kingdom
Phone: 44-0-161-606-7250 Fax: 44-0-161-606-7251


SEARCH JOBS




Industry
Biotechnology






 Company News
F2G Ltd, The UK-Based Antifungal Drug Discovery And Development Company, Today Announced A Major Funding Award From The Technology Strategy Board’s Biomedical Catalyst 9/9/2014 10:06:23 AM
F2G Ltd, The UK-Based Antifungal Drug Discovery And Development Company, Today Announces Commencement Of A Phase 1 Single Ascending Dose Study Of A Novel Antifungal Agent, F901318. 9/2/2014 4:07:07 PM
F2G Ltd and the University of Manchester Announce a New €6.1 Million Project to Develop New Antifungal Agents to Treat Resistant Fungal Infections 6/25/2013 10:14:17 AM
F2G Ltd Appoints Ian Nicholson as CEO 3/18/2013 9:05:45 AM
F2G Ltd Appoints John H. Rex to Board of Directors 2/19/2013 12:36:54 PM
F2G Ltd Raises $30 Million to Fund Pre-Clinical and Clinical Development of Novel Anti-Fungal Compounds 9/5/2012 6:40:47 AM
F2G Ltd Announces the Appointment of Michael R. Hodges, M.D. to the Board of Directors 9/13/2010 2:39:41 PM
F2G Ltd Announces the Appointment of Dr Richard J. White as Chairman of the Board of Directors 2/24/2010 2:19:37 PM
F2G Ltd Initiates Phase I Clinical Trial for FG3622 7/7/2009 10:55:22 AM
F2G Ltd Announces Key Appointment and a Consolidation of the Management Team 2/12/2009 11:59:23 AM
12